DocSym
β
Searchsearch
Search
(C78.7) Secondary malignant neoplasm of liver and intrahepatic bile duct
More details coming soon
3 390 234 in individuals diagnosis secondary malignant neoplasm of liver and intrahepatic bile duct confirmed
417 883 deaths with diagnosis secondary malignant neoplasm of liver and intrahepatic bile duct
12% mortality rate associated with the disease secondary malignant neoplasm of liver and intrahepatic bile duct
Diagnosis secondary malignant neoplasm of liver and intrahepatic bile duct is diagnosed Men are 0.43% more likely than Women
1 702 431
Men receive the diagnosis secondary malignant neoplasm of liver and intrahepatic bile duct
219 527 (12.9 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
1 687 803
Women receive the diagnosis secondary malignant neoplasm of liver and intrahepatic bile duct
198 356 (11.8 %)Died from this diagnosis.
Risk Group for the Disease secondary malignant neoplasm of liver and intrahepatic bile duct - Men aged 65-69 and Women aged 60-64
In Men diagnosis is most often set at age 0-95+
Less common in men the disease occurs at Age 0-1Less common in women the disease occurs at Age 0-1
In Women diagnosis is most often set at age 0-95+
Disease Features secondary malignant neoplasm of liver and intrahepatic bile duct
Absence or low individual and public risk
Secondary malignant neoplasm of liver and intrahepatic bile duct - what does this mean
Secondary malignant neoplasm of liver and intrahepatic bile duct is a condition where cancer that has spread from another part of the body to the liver and bile ducts. this type of cancer is usually caused by the spread of cancer from the lungs, pancreas, or other organs in the body.
What happens during the disease - secondary malignant neoplasm of liver and intrahepatic bile duct
The pathogenesis of secondary malignant neoplasm of the liver and intrahepatic bile duct is due to the spread of cancer cells from another part of the body to the liver and bile duct. this is usually caused by metastasis, where cancer cells from a primary tumor travel through the bloodstream or lymphatic system to the liver and bile duct, where they multiply and form a new tumor. this is often seen in advanced stages of cancer, when the primary tumor has spread to other parts of the body.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical examination
- Laboratory tests (e.g. blood tests, CT scans, MRI scans, ultrasound, PET scans)
- Biopsy (tissue sample)
- Endoscopic retrograde cholangiopancreatography (ERCP)
- Liver function tests
- Liver biopsy
- Imaging studies (e.g. CT, MRI, X-ray)
- Laparoscopy
- Angiography
- Genetic testing
Treatment and Medical Assistance
Main goal of the treatment: To reduce the size of the tumor and improve the overall health of the patient.
- Surgery to remove the tumor
- Chemotherapy
- Radiation therapy
- Targeted drug therapy
- Immunotherapy
- Biological therapy
- Clinical trials
16 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Secondary malignant neoplasm of liver and intrahepatic bile duct - Prevention
The best way to prevent secondary malignant neoplasms of the liver and intrahepatic bile duct is to reduce the risk factors associated with them. this includes maintaining a healthy lifestyle, avoiding alcohol and tobacco use, eating a balanced diet, and getting regular screenings. additionally, it is important to be aware of any symptoms that may be indicative of the disease and seek medical attention as soon as possible.